ClinConnect ClinConnect Logo
Search / Trial NCT06953648

Remotely Monitored, Mobile Health-supported, High Intensity Interval Training Before Hematopoietic Stem Cell Transplant

Launched by UNIVERSITY OF KANSAS MEDICAL CENTER · Apr 23, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

High Intensity Interval Training Hiit Hematopoietic Stem Cell Transplantation Remote Monitoring Mobile Health Exercise Cardiorespiratory Fitness

ClinConnect Summary

This clinical trial is looking at how a special exercise program called REMM-HIIT, which is monitored remotely, can improve fitness and physical abilities in patients who are about to undergo stem cell transplantation. The main questions researchers want to answer are whether this training helps participants get fitter and feel better physically. Participants in the study will be compared to a control group who won’t do the training to see if the exercise program makes a difference in their recovery after transplant.

To be eligible for this trial, participants need to be between 18 and 80 years old and planning to have a stem cell transplant in the next 4 to 12 weeks. They should be comfortable reading and writing in English and able to follow exercise coaching. Throughout the study, participants will complete various fitness tests, track their daily activity, and may even provide samples of blood and stool. This study is not yet recruiting, but it aims to help understand how exercise can support patients during a critical time in their treatment.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Plan to undergo allogeneic hematopoietic stem cell transplant in 4-12 weeks after enrollment on this study.
  • Age 18-80 years
  • Able to read/write English (as many participant-reported outcome measures lack validated translations in other languages)
  • Exclusion Criteria:
  • Unable or unwilling to follow coaching
  • Functional impairment resulting in inability to exercise
  • * Any absolute contraindications to exercise:
  • 1. recent (\<6 months) acute cardiac event;
  • 2. unstable angina;
  • 3. uncontrolled dysrhythmias causing symptoms;
  • 4. symptomatic aortic stenosis;
  • 5. uncontrolled symptomatic heart failure;
  • 6. acute pulmonary embolus;
  • 7. acute myocarditis or pericarditis;
  • 8. suspected or known dissecting aneurysm

About University Of Kansas Medical Center

The University of Kansas Medical Center (KUMC) is a leading academic medical institution dedicated to advancing healthcare through innovative research, education, and clinical practice. As a prominent clinical trial sponsor, KUMC leverages its extensive expertise in diverse medical fields to conduct rigorous clinical research aimed at improving patient outcomes and developing new treatment modalities. With a commitment to ethical standards and patient safety, KUMC collaborates with multidisciplinary teams to facilitate groundbreaking studies that address significant health challenges, ultimately contributing to the advancement of medical knowledge and the enhancement of community health.

Locations

Durham, North Carolina, United States

Kansas City, Kansas, United States

Houston, Texas, United States

Patients applied

0 patients applied

Trial Officials

Anthony Sung, MD

Principal Investigator

The University of Kansas Cancer Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported